Wskaźniki wartości rynkowej BAY (BAYER)
87.37-1.06(-1.20%)BAYER AG
2010/Q4 (gru 10) | 2011/Q4 (gru 11) | 2012/Q1 (mar 12) | 2012/Q2 (cze 12) | 2012/Q3 (wrz 12) | 2012/Q4 (gru 12) | 2013/Q1 (mar 13) | 2013/Q2 (cze 13) | 2013/Q3 (wrz 13) | 2013/Q4 (gru 13) | 2014/Q1 (mar 14) | 2014/Q2 (cze 14) | 2014/Q3 (wrz 14) | 2014/Q4 (gru 14) | 2015/Q1 (mar 15) | 2015/Q2 (cze 15) | 2015/Q3 (wrz 15) | 2015/Q4 (gru 15) | 2016/Q1 (mar 16) | 2016/Q2 (cze 16) | 2016/Q3 (wrz 16) | 2016/Q4 (gru 16) | 2017/Q1 (mar 17) | 2017/Q2 (cze 17) | 2017/Q3 (wrz 17) | 2017/Q4 (gru 17) | 2018/Q1 (mar 18) | 2018/Q2 (cze 18) | 2018/Q3 (wrz 18) | 2018/Q4 (gru 18) | 2019/Q1 (mar 19) | 2019/Q2 (cze 19) | 2019/Q3 (wrz 19) | 2019/Q4 (gru 19) | 2020/Q1 (mar 20) | 2020/Q2 (cze 20) | 2020/Q3 (wrz 20) | 2020/Q4 (gru 20) | 2021/Q1 (mar 21) | 2021/Q2 (cze 21) | 2021/Q3 (wrz 21) | 2021/Q4 (gru 21) | 2022/Q1 (mar 22) | 2022/Q2 (cze 22) | 2022/Q3 (wrz 22) | 2022/Q4 (gru 22) | 2023/Q1 (mar 23) | 2023/Q2 (cze 23) | 2023/Q3 (wrz 23) | 2023/Q4 (gru 23) | 2024/Q1 (mar 24) | 2024/Q2 (cze 24) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kurs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 235.00 | 209.00 | 148.56 | 123.50 | 112.66 | |
Liczba akcji | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 826 950 000 | 932 551 964 | 932 551 964 | 932 551 964 | 932 551 964 | 932 551 964 | 932 551 964 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | 982 424 082 | |
Wartość księgowa na akcję | 90.19 | 102.61 r/r +13.77% | 100.59 k/k -1.97% | 95.20 k/k -5.37% | 92.73 k/k -2.59% | 91.31 r/r -11.02% k/k -1.53% | 99.39 r/r -1.20% k/k +8.85% | 101.55 r/r +6.67% k/k +2.17% | 102.22 r/r +10.24% k/k +0.67% | 103.90 r/r +13.80% k/k +1.64% | 105.95 r/r +6.60% k/k +1.97% | 97.86 r/r -3.63% k/k -7.64% | 101.93 r/r -0.29% k/k +4.16% | 103.63 r/r -0.26% k/k +1.67% | 107.47 r/r +1.43% k/k +3.71% | 113.09 r/r +15.57% k/k +5.23% | 115.23 r/r +13.05% k/k +1.89% | 125.04 r/r +20.66% k/k +8.51% | 121.94 r/r +13.46% k/k -2.48% | 121.58 r/r +7.51% k/k -0.29% | 121.98 r/r +5.86% k/k +0.33% | 162.27 r/r +29.77% k/k +33.03% | 171.54 r/r +40.68% k/k +5.71% | 166.87 r/r +37.25% k/k -2.72% | 193.82 r/r +58.89% k/k +16.15% | 185.61 r/r +14.38% k/k -4.24% | 195.06 r/r +13.71% k/k +5.09% | 220.50 r/r +32.14% k/k +13.05% | 230.14 r/r +18.74% k/k +4.37% | 212.00 r/r +14.22% k/k -7.88% | 220.98 r/r +13.29% k/k +4.24% | 204.16 r/r -7.41% k/k -7.61% | 215.57 r/r -6.33% k/k +5.59% | 204.83 r/r -3.38% k/k -4.98% | 225.24 r/r +1.93% k/k +9.97% | 162.31 r/r -20.50% k/k -27.94% | 144.35 r/r -33.04% k/k -11.06% | 143.38 r/r -30.00% k/k -0.67% | 164.08 r/r -27.15% k/k +14.43% | 139.83 r/r -13.85% k/k -14.78% | 146.68 r/r +1.61% k/k +4.89% | 154.59 r/r +7.82% k/k +5.40% | 177.29 r/r +8.05% k/k +14.69% | 181.14 r/r +29.54% k/k +2.17% | 204.58 r/r +39.48% k/k +12.94% | 185.09 r/r +19.73% k/k -9.53% | 194.48 r/r +9.69% k/k +5.07% | 167.37 r/r -7.60% k/k -13.94% | 157.50 r/r -23.01% k/k -5.90% | 145.73 r/r -21.27% k/k -7.48% | 155.87 r/r -19.85% k/k +6.96% | 156.67 r/r -6.39% k/k +0.51% | |
Cena / Wartość księgowa | 1.40 | 1.33 k/k -5.50% | 1.02 k/k -23.17% | 0.79 k/k -22.28% | 0.72 r/r -48.79% k/k -9.24% | ||||||||||||||||||||||||||||||||||||||||||||||||
Wartość księgowa Grahama na akcję | -68.45 | -71.71 r/r -4.77% | -59.81 k/k +16.60% | -71.52 k/k -19.59% | -68.16 k/k +4.70% | -68.13 r/r +4.99% k/k +0.05% | -63.52 r/r -6.21% k/k +6.77% | -69.02 r/r +3.50% k/k -8.66% | -61.92 r/r +9.16% k/k +10.29% | -57.60 r/r +15.46% k/k +6.98% | -66.98 r/r -5.44% k/k -16.28% | -72.50 r/r -5.04% k/k -8.24% | -75.56 r/r -22.03% k/k -4.22% | -143.23 r/r -148.67% k/k -89.57% | -147.48 r/r -120.20% k/k -2.97% | -137.15 r/r -89.18% k/k +7.01% | -137.84 r/r -82.43% k/k -0.51% | -127.03 r/r +11.31% k/k +7.84% | -129.71 r/r +12.05% k/k -2.11% | -143.29 r/r -4.48% k/k -10.47% | -138.58 r/r -0.53% k/k +3.29% | -106.43 r/r +16.22% k/k +23.20% | -80.66 r/r +37.82% k/k +24.21% | -74.13 r/r +48.26% k/k +8.09% | -45.37 r/r +67.26% k/k +38.81% | -41.12 r/r +61.36% k/k +9.36% | -19.55 r/r +75.77% k/k +52.46% | -240.84 r/r -224.87% k/k -1132.07% | -214.81 r/r -373.52% k/k +10.81% | -226.88 r/r -451.73% k/k -5.62% | -227.96 r/r -1066.19% k/k -0.48% | -231.02 r/r +4.08% k/k -1.34% | -239.67 r/r -11.57% k/k -3.74% | -200.70 r/r +11.54% k/k +16.26% | -202.48 r/r +11.18% k/k -0.88% | -250.25 r/r -8.32% k/k -23.60% | -224.42 r/r +6.36% k/k +10.32% | -238.10 r/r -18.63% k/k -6.09% | -227.53 r/r -12.37% k/k +4.44% | -235.41 r/r +5.93% k/k -3.47% | -251.71 r/r -12.16% k/k -6.92% | -255.13 r/r -7.15% k/k -1.36% | -236.45 r/r -3.92% k/k +7.32% | -243.17 r/r -3.30% k/k -2.84% | -253.45 r/r -0.69% k/k -4.23% | -230.05 r/r +9.83% k/k +9.23% | -211.36 r/r +10.61% k/k +8.12% | -207.32 r/r +14.74% k/k +1.91% | -217.84 r/r +14.05% k/k -5.08% | -201.93 r/r +12.23% k/k +7.31% | -192.42 r/r +8.96% k/k +4.71% | -192.59 r/r +7.10% k/k -0.09% | |
Cena / Wartość księgowa Grahama | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Przychody ze sprzedaży na akcję | 168.04 | 195.10 r/r +16.10% | 190.54 k/k -2.34% | 198.32 k/k +4.08% | 200.22 k/k +0.96% | 196.56 r/r +0.75% k/k -1.83% | 201.14 r/r +5.57% k/k +2.33% | 203.00 r/r +2.36% k/k +0.92% | 204.02 r/r +1.90% k/k +0.50% | 201.39 r/r +2.46% k/k -1.29% | 206.23 r/r +2.53% k/k +2.40% | 202.44 r/r -0.27% k/k -1.84% | 206.90 r/r +1.41% k/k +2.20% | 217.71 r/r +8.10% k/k +5.23% | 220.88 r/r +7.10% k/k +1.46% | 230.55 r/r +13.89% k/k +4.38% | 233.49 r/r +12.86% k/k +1.28% | 238.72 r/r +9.65% k/k +2.24% | 236.65 r/r +7.14% k/k -0.87% | 239.39 r/r +3.83% k/k +1.16% | 241.55 r/r +3.45% k/k +0.90% | 250.20 r/r +4.81% k/k +3.58% | 252.40 r/r +6.66% k/k +0.88% | 251.86 r/r +5.21% k/k -0.21% | 198.25 r/r -17.92% k/k -21.28% | 176.61 r/r -29.42% k/k -10.92% | 157.30 r/r -37.68% k/k -10.93% | 128.57 r/r -48.95% k/k -18.26% | 169.40 r/r -14.55% k/k +31.76% | 182.53 r/r +3.36% k/k +7.75% | 200.75 r/r +27.63% k/k +9.98% | 208.77 r/r +62.39% k/k +4.00% | 202.31 r/r +19.43% k/k -3.10% | 188.75 r/r +3.41% k/k -6.70% | 192.75 r/r -3.98% k/k +2.12% | 188.75 r/r -9.59% k/k -2.08% | 191.02 r/r -5.58% k/k +1.20% | 194.47 r/r +3.03% k/k +1.81% | 190.33 r/r -1.26% k/k -2.13% | 194.57 r/r +3.08% k/k +2.23% | 201.50 r/r +5.49% k/k +3.56% | 206.37 r/r +6.12% k/k +2.42% | 217.45 r/r +14.25% k/k +5.37% | 228.58 r/r +17.48% k/k +5.12% | 238.37 r/r +18.30% k/k +4.28% | 242.22 r/r +17.37% k/k +1.61% | 242.76 r/r +11.64% k/k +0.22% | 231.71 r/r +1.37% k/k -4.55% | 224.59 r/r -5.78% k/k -3.07% | 210.83 r/r -12.96% k/k -6.13% | 211.59 r/r -12.84% k/k +0.36% | 210.48 r/r -9.16% k/k -0.52% | |
Cena / Przychody ze sprzedaży | 1.01 | 0.93 k/k -8.24% | 0.70 k/k -24.29% | 0.58 k/k -17.16% | 0.54 r/r -47.23% k/k -8.31% | ||||||||||||||||||||||||||||||||||||||||||||||||
Zysk na akcję | 6.23 | 13.19 r/r +111.74% | 14.38 k/k +9.00% | 13.26 k/k -7.81% | 12.57 k/k -5.16% | 12.09 r/r -8.34% k/k -3.83% | 12.93 r/r -10.09% k/k +6.91% | 14.85 r/r +12.03% k/k +14.88% | 15.85 r/r +26.05% k/k +6.71% | 15.99 r/r +32.26% k/k +0.91% | 17.60 r/r +36.13% k/k +10.05% | 17.99 r/r +21.14% k/k +2.23% | 18.43 r/r +16.26% k/k +2.41% | 17.66 r/r +10.41% k/k -4.16% | 16.56 r/r -5.89% k/k -6.20% | 17.61 r/r -2.12% k/k +6.33% | 18.78 r/r +1.93% k/k +6.64% | 21.18 r/r +19.94% k/k +12.77% | 22.14 r/r +33.68% k/k +4.54% | 23.68 r/r +34.48% k/k +6.96% | 24.53 r/r +30.62% k/k +3.58% | 24.24 r/r +14.45% k/k -1.19% | 26.63 r/r +20.26% k/k +9.85% | 25.50 r/r +7.66% k/k -4.24% | 39.53 r/r +61.14% k/k +55.04% | 37.00 r/r +52.64% k/k -6.40% | 37.17 r/r +39.59% k/k +0.46% | 31.15 r/r +22.17% k/k -16.19% | 26.44 r/r -33.13% k/k -15.13% | 7.82 r/r -78.88% k/k -70.44% | 4.49 r/r -87.91% k/k -42.50% | 2.60 r/r -91.66% k/k -42.17% | -5.78 r/r -121.86% k/k -322.38% | 17.73 r/r +126.89% k/k +406.81% | 19.37 r/r +331.06% k/k +9.24% | -25.78 r/r -1091.92% k/k -233.09% | -43.02 r/r -644.30% k/k -66.86% | -49.30 r/r -378.03% k/k -14.61% | -44.70 r/r -330.73% k/k +9.34% | -12.04 r/r +53.31% k/k +73.07% | 1.01 r/r +102.34% k/k +108.37% | 4.68 r/r +109.50% k/k +364.68% | 10.68 r/r +123.89% k/k +128.05% | 20.00 r/r +266.17% k/k +87.34% | 22.31 r/r +2114.13% k/k +11.53% | 19.81 r/r +323.16% k/k -11.19% | 14.57 r/r +36.46% k/k -26.46% | 7.44 r/r -62.80% k/k -48.93% | -16.82 r/r -175.42% k/k -326.12% | -13.02 r/r -165.70% k/k +22.64% | -15.43 r/r -205.94% k/k -18.58% | -7.04 r/r -194.55% k/k +54.42% | |
Cena / Zysk | 31.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Zysk operacyjny na akcję | 13.07 | 22.16 r/r +69.50% | 23.57 k/k +6.35% | 21.24 k/k -9.86% | 19.63 k/k -7.60% | 19.58 r/r -11.66% k/k -0.26% | 20.64 r/r -12.41% k/k +5.44% | 23.57 r/r +10.93% k/k +14.17% | 25.54 r/r +30.13% k/k +8.39% | 24.74 r/r +26.39% k/k -3.13% | 26.82 r/r +29.93% k/k +8.39% | 27.15 r/r +15.20% k/k +1.22% | 28.22 r/r +10.47% k/k +3.94% | 28.38 r/r +14.69% k/k +0.57% | 27.13 r/r +1.16% k/k -4.40% | 29.09 r/r +7.16% k/k +7.22% | 29.82 r/r +5.66% k/k +2.49% | 32.21 r/r +13.49% k/k +8.02% | 33.78 r/r +24.49% k/k +4.87% | 36.11 r/r +24.15% k/k +6.92% | 37.45 r/r +25.61% k/k +3.71% | 37.67 r/r +16.97% k/k +0.59% | 40.84 r/r +20.92% k/k +8.41% | 40.47 r/r +12.07% k/k -0.90% | 31.17 r/r -16.77% k/k -22.98% | 29.77 r/r -20.97% k/k -4.49% | 25.96 r/r -36.44% k/k -12.81% | 19.59 r/r -51.60% k/k -24.54% | 39.80 r/r +27.67% k/k +103.16% | 18.05 r/r -39.38% k/k -54.65% | 16.34 r/r -37.04% k/k -9.44% | 14.25 r/r -27.27% k/k -12.83% | -1.71 r/r -104.30% k/k -112.01% | 8.71 r/r -51.72% k/k +609.25% | 11.94 r/r -26.94% k/k +37.05% | -41.09 r/r -388.40% k/k -444.10% | -88.48 r/r -5071.58% k/k -115.34% | -75.95 r/r -971.73% k/k +14.16% | -70.59 r/r -691.15% k/k +7.06% | -32.06 r/r +21.97% k/k +54.58% | 13.74 r/r +115.53% k/k +142.87% | 15.70 r/r +120.67% k/k +14.21% | 21.41 r/r +130.33% k/k +36.40% | 32.71 r/r +202.03% k/k +52.78% | 36.16 r/r +163.07% k/k +10.53% | 33.47 r/r +113.24% k/k -7.42% | 27.73 r/r +29.53% k/k -17.15% | 22.60 r/r -30.92% k/k -18.52% | -0.30 r/r -100.84% k/k -101.35% | 2.71 r/r -91.91% k/k +990.99% | 1.94 r/r -93.02% k/k -28.55% | 8.57 r/r -62.07% k/k +342.87% | |
Cena / Zysk operacyjny | 10.40 | 54.85 | 63.81 k/k +16.35% | 13.14 r/r +26.40% k/k -79.40% | |||||||||||||||||||||||||||||||||||||||||||||||||
Enterprise Value na akcję | 425.42 | 400.61 k/k -5.83% | 321.60 k/k -19.72% | 305.37 k/k -5.05% | 300.08 r/r -29.46% k/k -1.73% | ||||||||||||||||||||||||||||||||||||||||||||||||
EV / Przychody ze sprzedaży | 1.84 | 1.78 k/k -2.85% | 1.53 k/k -14.48% | 1.44 k/k -5.39% | 1.43 r/r -22.35% k/k -1.21% | ||||||||||||||||||||||||||||||||||||||||||||||||
EV / EBIT | 18.83 | -1 317.91 k/k -7100.59% | 118.74 k/k +109.01% | 157.79 k/k +32.89% | 35.01 r/r +85.98% k/k -77.81% | ||||||||||||||||||||||||||||||||||||||||||||||||
EV / EBITDA | 7.32 | 7.55 k/k +3.17% | 6.83 k/k -9.48% | 6.50 k/k -4.91% | 6.86 r/r -6.27% k/k +5.55% |
Wskaźniki obliczane są na podstawie urocznionych wartości RZiS i PP z 4 ostatnich raportów kwartalnych.
Wartości dla sektora obliczane są w oparciu o medianę.
Informacje
ISIN: | DE000BAY0017 |
---|---|
Liczba akcji: | 826 950 000 |
Kapitalizacja: | 72 250 621 500 |
Enterprise Value: | 256 372 591 500 |
Branża: | Produkcja leków |
Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals... Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals koncentruje się na badaniach, opracowywaniu i sprzedaży produktów na receptę i specjalistycznych terapii, szczególnie w dziedzinie kardiologii, onkologii, ginekologii, hematologii i okulistyki, a także radiofarmakologii i innych. Segment Consumer Health opracowuje, produkuje i sprzedaje bez recepty produkty dostępne bez recepty w zakresie m.in. dermatologii, suplementów diety, leków przeciwbólowych, przewodu pokarmowego, przeziębienia, alergii, zatok i grypy, pielęgnacji stóp i ochrony przeciwsłonecznej. Segment Crop Science bada, rozwija i wprowadza na rynek rozwiązania i nasiona do ochrony roślin, a także obejmuje spółkę zależną Monsanto. Segment Animal Health zajmuje się opracowywaniem, produkcją i marketingiem weterynaryjnych produktów na receptę i bez recepty.
Nazwa: | BAYER AG |
---|---|
Adres: | Werk Leverkusen, 51-368, Leverkusen, Deutschland |
CEO: | Bill Anderson |
Telefon: | +49 (0) 214 30-1 |
WWW: | http://www.bayer.com/ |